Literature DB >> 8570199

A single ets-related transcription factor, E1AF, confers invasive phenotype on human cancer cells.

M Kaya1, K Yoshida, F Higashino, T Mitaka, S Ishii, K Fujinaga.   

Abstract

Invasion of cancer cells is the first step of metastasis. The invasive activity is thought to be dependent on the production of matrix metalloproteinases (MMPs). The transcription regulatory regions of MMP genes often contain binding sites for Ets and AP-1 transcription factors and they mediate oncogene- and growth factor-induced transcription of the genes. We recently isolated the cDNA encoding human E1AF, a new member of ets oncogene family. E1AF highly stimulated transcription from three different subclasses of MMP genes in transient expression assays. Here we show that transfection of the non-invasive human breast cancer cell line MCF-7 with the E1AF expression plasmid results in induction of invasive and motile activities, accompanied by an increase of 92 kD type IV collagenase (MMP-9) gene expression. Tumors derived from the E1AF transfectant were highly invasive and produced MMP-9. Expression of E1AF and MMP-9 genes was elevated in several invasive tumor cell lines. These results provide evidence for an important role of ets-related E1AF in tumor cell invasion.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8570199

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  23 in total

Review 1.  Function of PEA3 Ets transcription factors in mammary gland development and oncogenesis.

Authors:  Natasza A Kurpios; Nancy A Sabolic; Trevor G Shepherd; Gina M Fidalgo; John A Hassell
Journal:  J Mammary Gland Biol Neoplasia       Date:  2003-04       Impact factor: 2.673

2.  The ETS family member ERM contains an alpha-helical acidic activation domain that contacts TAFII60.

Authors:  P A Defossez; J L Baert; M Monnot; Y de Launoit
Journal:  Nucleic Acids Res       Date:  1997-11-15       Impact factor: 16.971

Review 3.  ETV1, 4 and 5: an oncogenic subfamily of ETS transcription factors.

Authors:  Sangphil Oh; Sook Shin; Ralf Janknecht
Journal:  Biochim Biophys Acta       Date:  2012-03-08

4.  Antisense E1AF transfection restrains oral cancer invasion by reducing matrix metalloproteinase activities.

Authors:  K Hida; M Shindoh; M Yasuda; M Hanzawa; K Funaoka; T Kohgo; A Amemiya; Y Totsuka; K Yoshida; K Fujinaga
Journal:  Am J Pathol       Date:  1997-06       Impact factor: 4.307

5.  Correlated expression of matrix metalloproteinases and ets family transcription factor E1A-F in invasive oral squamous-cell-carcinoma-derived cell lines.

Authors:  M Shindoh; F Higashino; M Kaya; M Yasuda; K Funaoka; M Hanzawa; K Hida; T Kohgo; A Amemiya; K Yoshida; K Fujinaga
Journal:  Am J Pathol       Date:  1996-03       Impact factor: 4.307

Review 6.  Role of Ets transcription factors in mammary gland development and oncogenesis.

Authors:  T Shepherd; J A Hassell
Journal:  J Mammary Gland Biol Neoplasia       Date:  2001-01       Impact factor: 2.673

7.  Expression of maspin in prostate cells is regulated by a positive ets element and a negative hormonal responsive element site recognized by androgen receptor.

Authors:  M Zhang; D Magit; R Sager
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-27       Impact factor: 11.205

8.  Expression of c-ets-1 mRNA is associated with an invasive, EMT-derived phenotype in breast carcinoma cell lines.

Authors:  C Gilles; M Polette; P Birembaut; N Brünner; E W Thompson
Journal:  Clin Exp Metastasis       Date:  1997-09       Impact factor: 5.150

9.  Ectopic expression of the ets transcription factor ER81 in transgenic mouse mammary gland enhances both urokinase plasminogen activator and stromelysin-1 transcription.

Authors:  Sonia Netzer; Frauke Leenders; Patrick Dumont; Jean-Luc Baert; Yvan de Launoit
Journal:  Transgenic Res       Date:  2002-04       Impact factor: 2.788

10.  Pea3 transcription factors and wnt1-induced mouse mammary neoplasia.

Authors:  Rebecca Baker; Claire V Kent; Rachel A Silbermann; John A Hassell; Lawrence J T Young; Louise R Howe
Journal:  PLoS One       Date:  2010-01-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.